Literature DB >> 709517

Initial levels of CEA and their rate of change in pancreatic carcinoma following surgery chemotherapy and radiation therapy.

J S Barkin, M H Kalser, R Kaplan, D Redlhammer, A Heal.   

Abstract

CEA levels and their rate of change in 41 patients with pancreatic carcinoma following surgery, chemotherapy and radiation therapy were determined. Surgical resection, though not curative, was associated with a decrease in CEA level, with approximately half these levels returned to normal. No correlation with survival was noted. CEA levels are increased by obstructive jaundice. Radiation alone or in combination with 5-Fluorouracil did not change CEA levels in patients with locally unresectable pancreatic carcinoma. CEA levels progressively increased in patients with widespread metastatic pancreatic carcinoma, who expired from their disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709517     DOI: 10.1002/1097-0142(197809)42:3+<1472::aid-cncr2820420817>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Serologic markers in the diagnosis and management of pancreatic carcinoma.

Authors:  D K Podolsky
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

2.  Signet ring carcinoma of the pancreas, a rare variant with very high CEA values. Immunohistologic comparison with adenocarcinoma.

Authors:  K J Tracey; M J O'Brien; L F Williams; M Klibaner; P K George; C A Saravis; N Zamcheck
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

3.  Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma.

Authors:  M Tatsuta; H Yamamura; S Noguchi; M Ichii; H Iishi; S Okuda
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 4.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.

Authors:  J Lundin; P J Roberts; P Kuusela; C Haglund
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.